SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-19-000084
Filing Date
2019-08-08
Accepted
2019-08-08 16:11:32
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opnt0630201910q.htm 10-Q 756065
2 EXHIBIT 31.10 exhibit31106302019.htm EX-31.10 12541
3 EXHIBIT 31.20 exhibit31206302019.htm EX-31.20 12633
4 EXHIBIT 32.10 exhibit32106302019.htm EX-32.10 5816
5 EXHIBIT 32.20 exhibit32206302019.htm EX-32.20 5578
  Complete submission text file 0001385508-19-000084.txt   4081216

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opnt-20190630.xml EX-101.INS 619858
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20190630.xsd EX-101.SCH 46107
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20190630_cal.xml EX-101.CAL 47771
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20190630_def.xml EX-101.DEF 222022
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20190630_lab.xml EX-101.LAB 519961
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20190630_pre.xml EX-101.PRE 330403
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 191009617
SIC: 1000 Metal Mining